Given that RCC is fundamentally chemotherapy and radiotherapy resistant, surgery serves to be the cornerstone of treatment for TFE3-rearranged RCC with modern literature citing the utility of targeted chemotherapy and checkpoint inhibitors (6). The gene discussed is TFE3; the disease is renal cell carcinoma.